Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tonix Pharm Holdings (NQ: TNXP ) 0.1412 +0.0012 (+0.86%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Tonix Pharm Holdings < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) and Kenya Medical Research Institute Partner on Phase I Trial for Mpox and Smallpox Vaccine TNX-801 November 04, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Promising Mpox Vaccine Data at World Vaccine Congress November 01, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at BIO-Europe in Stockholm October 29, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at ThinkEquity Conference October 25, 2024 Via Investor Brand Network Exposures Product Safety (TNXP) - Analyzing Tonix Pharmaceuticals's Short Interest October 22, 2024 Via Benzinga Looking Into Tonix Pharmaceuticals's Recent Short Interest September 19, 2024 Via Benzinga As Research Into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets It With FDA-Fast Track-Designated TNX-102 SL September 04, 2024 Via ACCESSWIRE BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Mpox Vaccine Research at World Vaccine Congress Europe 2024 October 24, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives First Payment from U.S. Defense Agency to Develop Broad-Spectrum Antiviral Agents October 17, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Submits New Drug Application to FDA for TNX-102 SL for Fibromyalgia Treatment October 16, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), X-Chem to Collaborate in Development of Broad-Spectrum Antivirals October 08, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Why Tonix Pharmaceuticals (TNXP) Stock Is Moving October 08, 2024 Tonix Pharmaceuticals shares are trading higher by 8% during Tuesday's session. The company secured a $34 million DOD research collaboration contract with X-Chem. Via Benzinga AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances October 01, 2024 AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances Via News Direct Topics Artificial Intelligence Exposures Artificial Intelligence InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Featured in Post Discussing Nonaddictive Painkillers Designed to Counter Opioid Crisis October 01, 2024 Via Investor Brand Network Exposures Product Safety The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions October 01, 2024 Via ACCESSWIRE BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins Expert Panel at Long COVID, RECOVER TLC Workshop September 30, 2024 Via Investor Brand Network Exposures COVID-19 Product Safety AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances September 30, 2024 AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances Via News Direct Topics Artificial Intelligence Exposures Artificial Intelligence What's Going On With Tonix Pharmaceuticals Stock Friday? September 27, 2024 Tonix shares are trading higher Friday after the company announced the United States Patent and Trademark Office granted a patent covering the subcutaneous delivery of Zembrace Symtouch for treating... Via Benzinga Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) Receives New US Patent for Subcutaneous Administration of Zembrace(R) SymTouch(R) to Treat Migraines September 27, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations September 23, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines September 19, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) TNX-801 Positioned as Viable Contender in Global Fight Against Mpox September 18, 2024 Via Investor Brand Network Exposures Product Safety New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution September 18, 2024 Via ACCESSWIRE BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports TNX-801 Aligns with WHO Preferred TPP for Mpox Vaccines September 16, 2024 Via Investor Brand Network BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Names Seasoned Veteran as New EVP of Commercial Operations September 10, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data Demonstrating TNX-801’s Single-Dose Immune Protection Against Mpox September 09, 2024 Via Investor Brand Network Exposures Product Safety What's Going On With Tonix Pharmaceuticals (TNXP) Stock? September 09, 2024 Tonix Pharmaceuticals shares jumped 38% after presenting data on TNX-801, a potential single-dose mpox vaccine. Preclinical studies suggest it could block transmission and offer improved protection. Via Benzinga Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket September 09, 2024 Via Benzinga InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches Educational Campaign to Inspire Patients to Optimize Migraine Treatment Plans with Non-Oral Medication September 06, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Developing Fast-Track-Designated Treatment for Fibromyalgia September 04, 2024 Via Investor Brand Network Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
